Digital Media Net - Your Gateway To Digital media Creation. News and information on Digital Video, VR, Animation, Visual Effects, Mac Based media. Post Production, CAD, Sound and Music
MADRID–(BUSINESS WIRE)–After two years, Kevin Comadran’s Medabots gaming brand has been officially recognised in Japan, thereby consolidating his video game’s rights worldwide.
The Medabots video game, which will be released on iOS and Android, is a game of battles between robots with interchangeable parts, each with its own power and particular feature. It is a turn-based game with two modes: Single player (story mode with levels) and Multiplayer, played online against other players who are beaten by winning parts from them. The game also has an online shop where users can sell their parts.
Last month, Kevin Comadran also launched the Medacoin cryptocurrency, which will work within the game for players to buy parts and robots. His cryptocurrency has already been listed on LBank and he is in negotiations with other exchanges.
In the first two weeks of its launch, his Medacoin achieved a market capitalisation of $93 million. The game is recruiting ambassadors, including Bitboy and “The Cousins” from Breaking Bad, with other internationally recognised celebrities joining soon.
Kevin Comadran plans to launch the Medabots game this Christmas and pre-release access will be available to those in the Medacoin community. The game is being developed with a Triple-A team. On its official channel, Medabots already has 14,000 people registered and waiting for the game to be released.
https://t.me/MedabotsOfficialChannel
Contacts
Miguel Ramos
mramos@newsline.es
Tel. +34 609336891
SOLANA BEACH, Calif.--(BUSINESS WIRE)--Macnica Americas today announced the appointment of Nestor Amaya as Vice President…
Every year, millions of Americans who miss their tax filing deadlines assume the IRS is…
Genius Sports has deployed its cutting-edge data and AI platform GeniusIQ in every Liga MX…
Starting June 4, My Best Buy Plus™ and My Best Buy Total™ members will automatically…
New platform combines 17 years of proprietary compliance data with direct access to credentialed experts,…
Translational Data Inform a Scalable, Noninvasive Test Designed to Identify Treatment-Eligible Patients and Enable Longitudinal…